333 related articles for article (PubMed ID: 17903141)
1. Routine antenatal anti-D prophylaxis and patient compliance with the two-dose regimen.
Chaffe B; Ford J; Bills V
Transfus Med; 2007 Oct; 17(5):399-403. PubMed ID: 17903141
[TBL] [Abstract][Full Text] [Related]
2. The economics of routine antenatal anti-D prophylaxis for pregnant women who are rhesus negative.
Chilcott J; Tappenden P; Lloyd Jones M; Wight J; Forman K; Wray J; Beverley C
BJOG; 2004 Sep; 111(9):903-7. PubMed ID: 15327602
[TBL] [Abstract][Full Text] [Related]
3. The kinetics of routine antenatal prophylactic intramuscular injections of polyclonal anti-D immunoglobulin.
MacKenzie IZ; Roseman F; Findlay J; Thompson K; Jackson E; Scott J; Reed M
BJOG; 2006 Jan; 113(1):97-101. PubMed ID: 16398777
[TBL] [Abstract][Full Text] [Related]
4. Consequences of being Rhesus D immunized during pregnancy and how to optimize new prevention strategies.
Tiblad E; Westgren M; Pasupathy D; Karlsson A; Wikman AT
Acta Obstet Gynecol Scand; 2013 Sep; 92(9):1079-85. PubMed ID: 23750781
[TBL] [Abstract][Full Text] [Related]
5. Compliance with routine antenatal rhesus D prophylaxis and the impact on sensitisations: observations over 14 years.
MacKenzie IZ; Findlay J; Thompson K; Roseman F
BJOG; 2006 Jul; 113(7):839-43. PubMed ID: 16827770
[TBL] [Abstract][Full Text] [Related]
6. One single dose of 200 microg of antenatal RhIG halves the risk of anti-D immunization and hemolytic disease of the fetus and newborn in the next pregnancy.
Koelewijn JM; de Haas M; Vrijkotte TG; Bonsel GJ; van der Schoot CE
Transfusion; 2008 Aug; 48(8):1721-9. PubMed ID: 18507749
[TBL] [Abstract][Full Text] [Related]
7. An audit of the investigation and use of anti-D immunoglobulin prophylaxis in Tayside.
Rennie I; Smith A; Smith R; Rawlinson PS; Clark P
Health Bull (Edinb); 2001 May; 59(3):150-4. PubMed ID: 12664753
[TBL] [Abstract][Full Text] [Related]
8. [Prevention of fetomaternal rhesus-D allo-immunization. Practical aspects].
Cortey A; Brossard Y
J Gynecol Obstet Biol Reprod (Paris); 2006 Feb; 35(1 Suppl):1S123-1S130. PubMed ID: 16495838
[TBL] [Abstract][Full Text] [Related]
9. Clinical validation of routine antenatal anti-D prophylaxis questions the modelling predictions adopted by NICE for Rhesus D sensitisation rates: results of a longitudinal study.
Mackenzie IZ; Roseman F; Findlay J; Thompson K; McPherson K
Eur J Obstet Gynecol Reprod Biol; 2008 Jul; 139(1):38-42. PubMed ID: 18243487
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of anti-D IgG in pregnant RhD-negative women.
Bichler J; Schöndorfer G; Pabst G; Andresen I
BJOG; 2003 Jan; 110(1):39-45. PubMed ID: 12504934
[TBL] [Abstract][Full Text] [Related]
11. Implementation of NICE recommendation for a policy of routine antenatal anti-D prophylaxis: a survey of UK maternity units.
Harkness M; Freer Y; Prescott RJ; Warner P
Transfus Med; 2008 Oct; 18(5):292-5. PubMed ID: 18937736
[TBL] [Abstract][Full Text] [Related]
12. [Adverse effects and patient information].
Cortey A; Brossard Y
J Gynecol Obstet Biol Reprod (Paris); 2006 Feb; 35(1 Suppl):1S112-1S118. PubMed ID: 16495836
[TBL] [Abstract][Full Text] [Related]
13. Costs and benefits of non-invasive fetal RhD determination.
Teitelbaum L; Metcalfe A; Clarke G; Parboosingh JS; Wilson RD; Johnson JM
Ultrasound Obstet Gynecol; 2015 Jan; 45(1):84-8. PubMed ID: 25380024
[TBL] [Abstract][Full Text] [Related]
14. [Prenatal immunoglobulin prevention in Rh(D)-negative nonsensitized pregnant women].
Katsulov A
Akush Ginekol (Sofiia); 1997; 36(2):1-2. PubMed ID: 9471891
[No Abstract] [Full Text] [Related]
15. The fetal and neonatal outcomes of Rhesus D antibody affected pregnancies in Northern Ireland.
Craig S; Morris K; Tubman T; McClure B
Ir Med J; 2000; 93(1):17-8. PubMed ID: 10740367
[TBL] [Abstract][Full Text] [Related]
16. An increased risk for non allo-immunization related intrauterine fetal death in RhD-negative patients.
Ben-David G; Sheiner E; Levy A; Erez O; Mazor M
J Matern Fetal Neonatal Med; 2008 Apr; 21(4):255-9. PubMed ID: 18330822
[TBL] [Abstract][Full Text] [Related]
17. The scientific basis of antenatal prophylaxis.
Urbaniak SJ
Br J Obstet Gynaecol; 1998 Nov; 105 Suppl 18():11-8. PubMed ID: 9863973
[TBL] [Abstract][Full Text] [Related]
18. Time points and risk factors for RhD immunizations after the implementation of targeted routine antenatal anti-D prophylaxis: A retrospective nationwide cohort study.
Jernman R; Isaksson C; Haimila K; Kuosmanen M; Mäkikallio-Anttila K; Toivonen S; Ordén MR; Sulin K; Tihtonen K; Vääräsmäki M; Sainio S
Acta Obstet Gynecol Scand; 2021 Oct; 100(10):1868-1875. PubMed ID: 34157128
[TBL] [Abstract][Full Text] [Related]
19. [Antenatal anti-Rh(D) antigen prophylaxis of Rh/-/- pregnancy in women on first consultation at the St. Sofia Obstetrics-Gynecology Hospital -- Sofia].
Katsulov A; Iankov M; Zlateva K; Blagova A; Gogova K; Savova S
Akush Ginekol (Sofiia); 2001; 40 Suppl 5():7-8. PubMed ID: 11785356
[No Abstract] [Full Text] [Related]
20. Routine antenatal Rhesus D immunoglobulin prophylaxis: the results of a prospective 10 year study.
MacKenzie IZ; Bowell P; Gregory H; Pratt G; Guest C; Entwistle CC
Br J Obstet Gynaecol; 1999 May; 106(5):492-7. PubMed ID: 10430201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
